Indian expert group to re-examine spurious drug definitions
This article was originally published in Scrip
Executive Summary
India has constituted an expert group to examine the definitions of spurious, adulterated and misbranded drugs in the Drugs and Cosmetic Act and recommend changes to these in the context of "present trade practices followed nationally and internationally".